Skip to main content

GCO

Stock
Consumer Discretionary
Apparel Retail

Performance overview

GCO Price
Price Chart

Forward-looking statistics

Beta
1.08
Risk
53.57%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.

Company info

SectorConsumer Discretionary
IndustryApparel Retail
Employees10K
Market cap$303.4M

Fundamentals

Enterprise value$828.7M
Revenue$2.3B
Revenue per employee—
Profit margin-0.67%
Debt to equity122.05

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$1.60
Dividend per share—
Revenue per share$218.27
Avg trading volume (30 day)$7M
Avg trading volume (10 day)$6M
Put-call ratio—

Macro factor sensitivity

Growth+5.4
Credit+7.0
Liquidity-2.5
Inflation+1.9
Commodities+0.3
Interest Rates-3.2

Valuation

Dividend yield0.00%
PEG Ratio11.35
Price to sales0.10
P/E Ratio11.35
Enterprise Value to Revenue0.35
Price to book0.46

Upcoming events

Next earnings dayMarch 7, 2025
Next dividend day—
Ex. dividend dayApril 9, 1973

News

Buy These 4 Stocks With Solid Net Profit Margins to Enhance Returns

NGS, ASC, ATGE and RGCO boast strong net margins, rising earnings and bullish analyst ratings that signal upside.

Zacks Investment Research (July 3, 2025)
Agco (AGCO) Upgraded to Buy: Here's Why

Agco (AGCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (July 1, 2025)
Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

Shares of Regencell Bioscience, a Hong Kong-based developer of traditional Chinese herbal treatments that it says can treat childhood ADHD and autism, more than tripled Monday. The stock soared more than 280% after a 38-for-1 stock split.

CNBC (June 17, 2025)
Genesco (GCO) Reports Q1 Loss, Tops Revenue Estimates

Genesco (GCO) came out with a quarterly loss of $2.05 per share versus the Zacks Consensus Estimate of a loss of $2.09. This compares to loss of $2.10 per share a year ago.

Zacks Investment Research (June 4, 2025)
Top 3 Consumer Stocks That May Rocket Higher This Quarter

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.

Benzinga (March 21, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free